Your browser doesn't support javascript.
loading
Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer.
Zahoor, Haris; Mir, Maria C; Barata, Pedro C; Stephenson, Andrew J; Campbell, Steven C; Fergany, Amr; Dreicer, Robert; Garcia, Jorge A.
Afiliação
  • Zahoor H; Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA.
  • Mir MC; Urology Department, IMED Valencia Hospital, Valencia, Spain.
  • Barata PC; Department of Internal Medicine, Section of Hematology and Medical Oncology, Tulane Medical School, New Orleans, Louisiana, USA.
  • Stephenson AJ; Cleveland Clinic, Glickman Urological and Kidney Institute, 9500 Euclid Avenue/R35, Cleveland, OH, 44195, USA.
  • Campbell SC; Cleveland Clinic, Glickman Urological and Kidney Institute, 9500 Euclid Avenue/R35, Cleveland, OH, 44195, USA.
  • Fergany A; Cleveland Clinic, Glickman Urological and Kidney Institute, 9500 Euclid Avenue/R35, Cleveland, OH, 44195, USA.
  • Dreicer R; Division Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
  • Garcia JA; Cleveland Clinic, Glickman Urological and Kidney Institute, 9500 Euclid Avenue/R35, Cleveland, OH, 44195, USA. garciaj4@ccf.org.
Invest New Drugs ; 37(6): 1231-1238, 2019 12.
Article em En | MEDLINE | ID: mdl-31231785

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Inibidores de Proteínas Quinases / Sunitinibe / Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Inibidores de Proteínas Quinases / Sunitinibe / Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article